Parkman-Healthcare-Partners

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
91
Total Value
843125283
Accession Number
0001420506-25-001258
Form Type
13F-HR
Manager Name
Parkman-Healthcare-Partners
Data Enrichment
97% identified
88 identified3 unidentified

Holdings

91 positions • $843.1M total value
Manager:
Search and click to pin securities to the top
Syndax Pharmaceuticals Inc
Shares:595.0K
Value:$7.3M
% of Portfolio:0.9% ($7.3M/$843.1M)
ANI PHARMACEUTICALS INC
Shares:105.0K
Value:$7.0M
% of Portfolio:0.8% ($7.0M/$843.1M)
CASTLE BIOSCIENCES INC
Shares:350.6K
Value:$7.0M
% of Portfolio:0.8% ($7.0M/$843.1M)
LivaNova PLC
Shares:166.9K
Value:$6.6M
% of Portfolio:0.8% ($6.6M/$843.1M)
QuidelOrtho Corp
Shares:183.7K
Value:$6.4M
% of Portfolio:0.8% ($6.4M/$843.1M)
TREACE MEDICAL CONCEPTS, INC.
Shares:713.5K
Value:$6.0M
% of Portfolio:0.7% ($6.0M/$843.1M)
Xenon Pharmaceuticals Inc.
Shares:174.6K
Value:$5.9M
% of Portfolio:0.7% ($5.9M/$843.1M)
Doximity, Inc.
Shares:93.5K
Value:$5.4M
% of Portfolio:0.6% ($5.4M/$843.1M)
RESMED INC
Shares:22.6K
Value:$5.1M
% of Portfolio:0.6% ($5.1M/$843.1M)
VERACYTE, INC.
Shares:166.3K
Value:$4.9M
% of Portfolio:0.6% ($4.9M/$843.1M)
PRECIGEN, INC.
Shares:3.2M
Value:$4.8M
% of Portfolio:0.6% ($4.8M/$843.1M)
Mineralys Therapeutics, Inc.
Shares:293.9K
Value:$4.7M
% of Portfolio:0.6% ($4.7M/$843.1M)
AMICUS THERAPEUTICS, INC.
Shares:569.0K
Value:$4.6M
% of Portfolio:0.6% ($4.6M/$843.1M)
Alphatec Holdings, Inc.
Shares:446.1K
Value:$4.5M
% of Portfolio:0.5% ($4.5M/$843.1M)
Arcellx, Inc.
Shares:67.4K
Value:$4.4M
% of Portfolio:0.5% ($4.4M/$843.1M)
UroGen Pharma Ltd.
Shares:393.2K
Value:$4.3M
% of Portfolio:0.5% ($4.3M/$843.1M)
Nurix Therapeutics, Inc.
Shares:350.4K
Value:$4.2M
% of Portfolio:0.5% ($4.2M/$843.1M)
Pulmonx Corp
Shares:611.9K
Value:$4.1M
% of Portfolio:0.5% ($4.1M/$843.1M)
OptimizeRx Corp
Shares:475.0K
Value:$4.1M
% of Portfolio:0.5% ($4.1M/$843.1M)
Guardant Health, Inc.
Shares:89.3K
Value:$3.8M
% of Portfolio:0.5% ($3.8M/$843.1M)